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Tissue engineering is an advanced interdisciplinary field 
that  encompasses  the  design  of  artificial  implant 
materials for in vivo tissue regeneration where mimicking 
the natural extracellular matrix (ECM) is often pursued. 
The  natural  ECM  supports  organ  and  tissue  structure 
and function, and also regulates basic cellular functions 
like proliferation, growth, migration, differentiation, and 
survival. These functions are controlled through tissue-
specific constituents, such as collagens, laminins, fibro-
nectin  or  elastins,  as  well  as  functional  molecules  like 
growth  factors  or  matricellular  proteins,  among  others 
[1]. Novel biomaterials should allow for the gradual endo-
ge  nous remodeling of native tissue leading to the replace-
ment  of  implant  material,  manufactured  to  replace  a 
missing biological structure, with fully functional ECM 
and cells that existed at the implant site prior to damage.
The critical point during in vitro tissue engineering is 
to at least partially recreate conditions that mimic the 
natural  ECM  environment  for  particular  cell  types  in 
order to support their function. Since cell contact with 
the  biomaterial  surface  significantly  influences  cell 
behavior and performance, trends in biomaterial designs 
lean towards bioactive materials that can modulate and 
control cell behavior. In recent years, biomaterial designs 
have focused on the incorporation of signaling molecules 
into  scaffold  materials  rather  than  using  them  in  a 
diffusive or soluble form [1,2]. Among the most studied 
molecules  are  multifunctional  proteins  like  growth 
factors [3-7] or cytokines [8], while there are also reports 
on  the  incorporation  of  small  molecules  like  neuro-
transmitters  [9]  into  scaffold  materials  (Figure  1).  This 
review aims at highlighting examples of specific behavior 
of cell types that was enhanced with signaling molecules 
tethered to biomaterials.
Biomaterial-induced vascularization
The  development  of  novel  therapeutic  approaches  that 
stimulate the body to maintain the natural ability for new 
blood vessel formation is among challenges of tissue engi-
neering. Endothelial cells play a key role in angiogenesis, 
through  development  of  new  blood  vessels  from  pre-
existing vessels. Normally, endothelial cells have a low rate 
of proliferation but the proliferative capacity is retained 
and used during such events as wound healing. Fibroblast 
growth  factors  are  multi  functional  proteins  involved  in 
processes  of  proliferation  and  differentiation  of  a  wide 
variety  of  cells  and  tissues  through  their  stimulatory 
functions.  Sahni  and  colleagues  investigated  the  natural 
binding affinity of fibroblast growth factor-2 (FGF-2), also 
known as basic fibroblast growth factor (bFGF), to fibrin, a 
fibrous protein formed during wound healing processes, 
and  the  ability  of  FGF-2  to  influence  proliferation  of 
endothelial  cells  in  vitro  [7].  Their  results  showed  that 
fibrin-bound FGF-2 stimulated the growth and increased 
proliferation of endothelial cells, demonstrating the effect 
of surface immobilized FGF-2 on the proliferative capacity 
of  endothelial  cells.  West  and  colleagues  studied  the 
influence  of  bFGF  loaded  into  hydrogel  scaffolds  on 
smooth muscle cell (SMC) behavior [5]. The concentration 
gradient of bFGF within a gel led to the alignment of SMCs 
in the direction of increased bFGF concentration. More-
over,  the  bFGF  gradient  hydrogels  increased  SMC 
proliferation  by  approximately  41%  and  migration  by 
approximately  15%,  with  cell  migration  observed  in  the 
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control over cell mobility.
Vascular endothelial growth factor (VEGF) is the other 
angiogenic protein capable of regulating new blood vessel 
formation.  Influence  of  VEGF  on  cell  behavior  was 
studied by Zisch et al. [6]. VEGF enrichment of poly  ethy-
lene  glycol  (PEG)-peptide  hydrogels  was  critical  for  in 
vitro endothelial cell survival and migration within the 
gel environment. Also, hydrogel grafting on top of the 
embry  onic chick chorioallontoic membrane led to pro-
nounced VEGF-induced angiogenesis, with strong new 
blood vessel formation observed at the graft-membrane 
interface. A rat subcutaneous implant model with VEGF-
loaded  hydrogels  showed  complete  remodel  ing  of  the 
implant material into native-like, vascularized tissue.
Since locally induced angiogenesis plays an important 
role in tissue remodeling in vivo, in vitro strategies such 
as these may contribute significantly to new biomaterial 
designs that support therapeutic new vessel growth.
Modulation of cell proliferation and survival
A  major  challenge  in  the  tissue  engineering  field  is  to 
provide  the  environment  within  the  engineered  bio-
material to support cellular proliferation and survival, a 
hallmark  of  functional  tissue.  Mesenchymal  stem  cells 
(MSCs) are multipotent stem cells able to differentiate 
into  different  cell  types  for  regenerative  medicine  and 
tissue  engineering  needs.  In  vivo  animal  models  using 
MSCs  for  reconstitution  of  damaged  tissues  such  as 
cartilage, bone, muscle, and tendon have shown positive 
outcomes  and  promise  for  human  applications.  Many 
clinical  approaches  for  disease  treatment  using  MSCs, 
like  filling  large  bone  defects,  will  require  the  implan-
tation of MSCs loaded in or attached to scaffold materials 
and this could induce an inflammatory response causing 
large cell losses. Fan and coworkers proposed the incor-
pora  tion of epidermal growth factor (EGF) into a syn-
thetic polymer matrix material to increase cell survival 
under  such  conditions  [4].  They  found  that  surface-
exposed  EGF  promoted  cell  attachment  to  the  matrix 
material and increased MSC spreading and survival when 
compared with media containing solubilized EGF. Also, 
MSCs in contact with surface-tethered EGF displayed a 
higher resistance to cell death induced by proinflamatory 
cytokines. These findings provided insight into cell res-
ponses  to  bioactive  surfaces  and  the  need  to  provide 
local, spatially controlled distri  bution of signaling mole-
cules on a biomaterial surface. Improving MSC-implant 
interactions  has  the  potential  to  enhance  cell  survival 
significantly in clinical disease treatments.
Regeneration of neurons
Nerve growth factor (NGF) covalently immobilized on 
patterned  polydimethyl  siloxane  (PDMS)  surfaces  was 
studied for its potential to induce neuron responses [3]. 
PDMS is a highly viscoelastic polymer that upon cross-
linking and hardening molds the surface patterns it was 
cast  on.  Gomez  and  coworkers  [3]  investigated  the 
impact of microchannel-patterned PDMS surface on the 
rate  of  axon  initiation  and  overall  axon  length  of 
embryonic hippocampal neurons. The influence of NGF 
on axon formation was lower (27%) when compared to 
the influence of PDMS microtopography, which was the 
decisive factor leading to a 68% increase in axon initia-
tion.  Nevertheless,  the  immobilized  NGF  played  the 
major  role  in  enhancement  of  axon  length,  with  an 
increase of about 10%. The most pronounced effect was 
observed  when  the  two  stimuli,  microchannels  and 
tethered NGF, were present simultaneously on the PDMS 
surface, resulting in a synergistic 25% increase in axon 
length with enhanced initiation due to surface topo  graphy 
and  improved  growth  from  NGF.  Another  interesting 
approach to stimulate neurite outgrowth was a bioactive 
diglycidyl  ester  polymer  bearing  dopamine  residues  [9]. 
The neurotransmitter activity enhanced neurite outgrowth 
and  induced  differentiation  in  rat  pheochromocytoma 
(PC12) cells, while the diffusive dopamine added to the 
culture medium had a negligible effect.
Bone formation in vitro
There  is  a  high  demand  for  novel  bone  replacement 
materials that can actively support new bone tissue for-
mation  in  therapeutic  treatment  of  bone  loss  diseases. 
There are numerous reports on bone remodeling studies 
using  different  scaffolds  either  in  single  component  or 
multi-component systems. An example of bone remodel-
ing in vitro using bioactive molecules is the report from 
Birch and colleagues [10] where two different osteo  genesis-
promoting  ligands  were  immobilized  on  gold  surface. 
Figure 1. Examples of signaling molecules modulating cell 
behavior in bioactive materials for tissue engineering. The ability 
of cells to respond to the biomaterial in a controllable manner is a 
decisive factor in successful disease treatments using engineered 
implant materials. Signaling molecules involve multifunctional 
proteins such as growth factors and cytokines, as well as small 
molecules like neurotransmitters.
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(OPN),  a  prominent  component  of  mineralized  extra-
cellular  matrix  and  the  second  motif  that  supported 
osteoblast differentiation and function was derived from 
bone morphogenetic protein (BMP)-2, known to influ-
ence  the  development  of  bone  and  cartilage.  The  pro-
posed  strategy  involved  genetic  engineering  of  recom-
binant  fusion  proteins  where  each  motif  was  cloned 
between the bacterial protein TolAIII, which acted as a 
scaffold  material  to  support  and  expose  the  bioactive 
OPN  and  BMP-2  ligands,  and  Cysteine  containing  C-
terminus  tag,  used  to  self-assemble  the  constructs  on 
gold  surfaces.  This  system  provided  a  self-assembled 
mono  layer (SAM) of fusion protein construct on a gold 
surface  that  displayed  the  ligand  motifs  in  highly 
reproducible manner. This is a fundamental study that 
provides an insight into cell behavior in the presence of 
immobilized  bioactive  ligands.  The  OPN  construct 
promoted cellular adhesion and spreading of primary rat 
osteoblasts through the formation of vinculin adhesion 
sites. The BMP-2 constructs drove in vitro bone forma-
tion  for  over  28  days  without  the  addition  of  external 
osteogenic stimuli. The spatial patterning of the BMP-2 
ligand  led  to  the  local  control  of  osteogenesis  and 
mineralization of the extracellular matrix, offering insight 
into the spatial control of cell differentiation towards this 
phenotype.
Retention of stem cell phenotype
Diffusible leukemia inhibitory factor (LIF) is often used 
in mouse embryonic stem cell (mESC) culture to retain 
the cells in an undifferentiated state. Immobilization of 
cytokines such as LIF and stem cell factor (SCF) to maleic 
anhydride  copolymer  thin-film  coatings  proposed  by 
Alberti and coworkers [8] investigated control over stem 
cell fate through spatially constrained ligand presentation 
that provides quantitative control of the signaling ligands 
at  material-cell  interfaces.  The  results  showed  that 
mESCs  cultured  on  immobilized  LIF  surfaces  retained 
pluripotency for at least 2 weeks in culture and, more 
importantly,  that  the  immobilized  LIF  ligands  were 
capable  of  activating  the  LIF-specific  cellular  signaling 
pathways, which support the self-renewal of mESCs in 
vitro  in  a  dose-dependent  manner.  The  significance  of 
these  findings  comes  from  the  fact  that  in  vivo  LIF  is 
produced in two isoforms, a diffusible and also matrix-
associated form, where the concentration of LIF in both 
cases is a decisive factor in activation of the LIF-specific 
signaling pathway. Thus, achievement of precise quanti-
tative control over the polymer-immobilized LIF cytokine 
may have a great impact in the tissue engineering field. 
Additionally, ECM coatings on the polymer-LIF surfaces 
did  not  affect  the  ligand  accessibility  and  cell-ligand 
inter  action. This leads to controlling the cell fate through 
a synergistic effect of ECM of choice and an immobilized 
cytokine,  which  broadens  the  potential  applications  of 
this system.
The  work  discussed  in  this  review  represents  the 
emerging area of study aimed at influencing cell behavior 
through the use of signaling molecules immobilized in 
biomaterials for tissue engineering needs. These examples 
follow a trend towards ‘smart’ bioactive material designs 
where cell performance can be tuned through the control 
of dose and spatial distribution of bioactive compounds 
within tissue scaffolding materials.
Published: 19 May 2010
References
1.  Daley WP, Peters SB, Larsen M: Extracellular matrix dynamics in 
development and regenerative medicine. J Cell Sci 2008, 121:255-264.
2.  Bacáková L, Filová E, Rypácek F, Svorcík V, Starý V: Cell adhesion on artificial 
materials for tissue engineering. Physiol Res 2004, 53 Suppl 1:S35-45.
3.  Gomez N, Lu Y, Chen S, Schmidt CE: Immobilized nerve growth factor and 
microtopography have distinct effects on polarization versus axon 
elongation in hippocampal cells in culture. Biomaterials 2007, 28:271-284.
4.  Fan VH, Tamama K, Au A, Littrell R, Richardson LB, Wright JW, Wells A, Griffith 
LG: Tethered epidermal growth factor provides a survival advantage to 
mesenchymal stem cells. Stem Cells 2007, 25:1241-1251.
5.  DeLong SA, Moon JJ, West JL: Covalently immobilized gradients of bFGF on 
hydrogel scaffolds for directed cell migration. Biomaterials 2005, 
26:3227-3234.
6.  Zisch AH, Lutolf MP, Ehrbar M, Raeber GP, Rizzi SC, Davies N, Schmökel H, 
Bezuidenhout D, Djonov V, Zilla P, Hubbell JA: Cell-demanded release of 
VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized 
tissue growth. Faseb J 2003, 17:2260-2262.
7.  Sahni A, Sporn LA, Francis CW: Potentiation of endothelial cell proliferation 
by fibrin(ogen)-bound fibroblast growth factor-2. J Biol Chem 1999, 
274:14936-14941.
8.  Alberti K, Davey RE, Onishi K, George S, Salchert K, Seib FP, Bornhäuser M, 
Pompe T, Nagy A, Werner C, Zandstra PW: Functional immobilization of 
signaling proteins enables control of stem cell fate. Nat Methods 2008, 
5:645-650.
9.  Gao J, Kim YM, Coe H, Zern B, Sheppard B, Wang Y: A neuroinductive 
biomaterial based on dopamine. Proc Natl Acad Sci U S A 2006, 
103:16681-16686.
10.  Mitchell E, Chaffey BT, McCaskie AW, Lakey JH, Birch MA: Controlled spatial 
and conformational display of immobilised bone morphogenetic 
protein-2 and osteopontin signalling motifs regulates osteoblast 
adhesion and differentiation in vitro. BMC Biol 2010, 8:57.
doi:10.1186/1741-7007-8-59
Cite this article as: Mieszawska AJ, Kaplan DL: Smart biomaterials - 
regulating cell behavior through signaling molecules. BMC Biology 2010, 
8:59.
Mieszawska and Kaplan BMC Biology 2010, 8:59 
http://www.biomedcentral.com/1741-7007/8/59
Page 3 of 3